Research Article
Correlation between the Systemic Immunoinflammatory Index and Platelet–Lymphocyte Ratio in Patients with Adenomyosis
Table 1
Baseline characteristics of included patient by SII quartile.
| Characteristic | SII (min–max) | P value | Q1 (118.33–403.04) | Q2 (403.50–571.32) | Q3 (575.96–841.21) | Q4 (842.00–2933.89) |
| N | 116 | 123 | 124 | 120 | | Age (years, mean ± SD) | 46.53 ± 5.65 | 46.41 ± 5.65 | 46.54 ± 5.75 | 46.09 ± 5.59 | 0.921 | Gravidity (n) | 3 (0–9) | 3 (1–8) | 3 (0–8) | 3 (0–9) | 0.059 | Parity (n) | 2 (0–4) | 2 (1–5) | 2 (0–4) | 2 (0–4) | 0.176 | Gravidity (n, %) | | | | | 0.515 | 0 | 1 (0.86%) | 0 (0.00%) | 4 (3.23%) | 2 (1.67%) | | 1 | 8 (6.90%) | 8 (6.50%) | 10 (8.06%) | 8 (6.67%) | | 2 and more | 107 (92.24%) | 115 (93.50%) | 110 (88.71%) | 110 (91.67%) | | Parity (n, %) | | | | | 0.016 | 0 | 1 (0.86%) | 0 (0.00%) | 7 (5.65%) | 3 (2.50%) | | 1 | 54 (46.55%) | 47 (38.21%) | 48 (38.71%) | 38 (31.67%) | | 2 and more | 61 (52.59%) | 76 (61.79%) | 69 (55.65%) | 79 (65.83%) | | BMI (kg/m2, mean ± SD) | 24.70 ± 3.11 | 27.79 ± 26.88 | 25.16 ± 3.15 | 24.74 ± 3.34 | 0.248 | Menstrual regularity, n (%) | | | | | 0.362 | Regular | 111 (95.69%) | 114 (92.68%) | 120 (96.77%) | 111 (92.50%) | | Irregular | 5 (4.31%) | 9 (7.32%) | 4 (3.23%) | 9 (7.50%) | | Dysmenorrhea, n (%) | | | | | 0.416 | No | 57 (49.14%) | 61 (49.59%) | 50 (40.32%) | 58 (48.33%) | | Yes | 59 (50.86%) | 62 (50.41%) | 74 (59.68%) | 62 (51.67%) | | Menstrual volume | | | | | 0.019 | Low | 5 (4.31%) | 2 (1.63%) | 4 (3.23%) | 1 (0.83%) | | Moderate | 80 (68.97%) | 80 (65.04%) | 74 (59.68%) | 61 (50.83%) | | High | 31 (26.72%) | 41 (33.33%) | 46 (37.10%) | 58 (48.33%) | | Hypertension, n (%) | | | | | 0.217 | No | 100 (86.21%) | 112 (91.06%) | 106 (85.48%) | 111 (92.50%) | | Yes | 16 (13.79%) | 11 (8.94%) | 18 (14.52%) | 9 (7.50%) | | Diabetes, n (%) | | | | | 0.025 | No | 116 (100.00%) | 123 (100.00%) | 119 (95.97%) | 118 (98.33%) | | Yes | 0 (0.00%) | 0 (0.00%) | 5 (4.03%) | 2 (1.67%) | | Endometriosis, n (%) | | | | | 0.416 | No | 100 (86.21%) | 103 (83.74%) | 97 (78.23%) | 98 (81.67%) | | Yes | 16 (13.79%) | 20 (16.26%) | 27 (21.77%) | 22 (18.33%) | | Benign adnexal tumor, n (%) | | | | | 0.076 | No | 68 (58.62%) | 63 (51.22%) | 80 (64.52%) | 60 (50.00%) | | Yes | 48 (41.38%) | 60 (48.78%) | 44 (35.48%) | 60 (50.00%) | | Uterine leiomyoma | | | | | 0.897 | No | 49 (42.24%) | 53 (43.09%) | 49 (39.52%) | 53 (44.17%) | | Yes | 67 (57.76%) | 70 (56.91%) | 75 (60.48%) | 67 (55.83%) | | Uterine adenomyoma | | | | | 0.356 | No | 85 (73.28%) | 100 (81.30%) | 96 (77.42%) | 98 (81.67%) | | Yes | 31 (26.72%) | 23 (18.70%) | 28 (22.58%) | 22 (18.33%) | | Menopause | | | | | <0.001 | No | 104 (89.66%) | 117 (95.12%) | 123 (99.19%) | 120 (100.00%) | | Yes | 12 (10.34%) | 6 (4.88%) | 1 (0.81%) | 0 (0.00%) | | Anaemia | | | | | <0.001 | Normal | 67 (57.76%) | 46 (37.40%) | 42 (33.87%) | 23 (19.17%) | | Mild | 27 (23.28%) | 41 (33.33%) | 36 (29.03%) | 39 (32.50%) | | Moderate | 21 (18.10%) | 34 (27.64%) | 40 (32.26%) | 52 (43.33%) | | Severe | 1 (0.86%) | 2 (1.63%) | 6 (4.84%) | 6 (5.00%) | | Uterine volume (cm3) | 184.79 ± 129.50 | 193.84 ± 108.61 | 220.21 ± 170.14 | 241.00 ± 150.91 | 0.009 | Length (cm) | 7.09 ± 1.81 | 7.20 ± 1.45 | 7.38 ± 1.78 | 7.72 ± 1.81 | 0.028 | Width (cm) | 6.92 ± 1.77 | 7.07 ± 1.44 | 7.35 ± 1.84 | 7.61 ± 1.68 | 0.010 | Thickness (cm) | 6.21 ± 1.65 | 6.58 ± 1.51 | 6.66 ± 1.71 | 6.95 ± 1.62 | 0.006 | Hemoglobin | 112.66 ± 21.93 | 102.41 ± 21.74 | 100.09 ± 25.61 | 90.39 ± 20.49 | <0.001 | Platelet (109/L, mean ± SD) | 241.68 ± 53.80 | 281.20 ± 62.26 | 307.72 ± 76.08 | 354.57 ± 94.31 | <0.001 | Neutrophil (109/L, mean ± SD) | 2.75 ± 0.89 | 3.23 ± 0.97 | 4.07 ± 1.06 | 5.46 ± 2.16 | <0.001 | Lymphocyte (109/L, mean ± SD) | 2.10 ± 0.57 | 1.85 ± 0.54 | 1.79 ± 0.59 | 1.47 ± 0.41 | <0.001 | SII (mean ± SD) | 312.77 ± 68.19 | 480.99 ± 46.65 | 694.64 ± 77.47 | 1306.82 ± 468.09 | <0.001 | PLR (mean ± SD) | 120.84 ± 34.71 | 161.07 ± 48.00 | 181.17 ± 46.56 | 255.46 ± 85.26 | <0.001 |
|
|